Interventional Recruiting
NCT06981065 on ClinicalTrials.gov
The Scandinavian Displaced Lateral Clavicle Trial
Official title: The Scandinavian Displaced Lateral Clavicle Trial (ScanDiLaC) - A Multicentre, Pragmatic, 12-Month, Non-inferiority, Randomized Controlled Trial
- Sponsor: Uppsala University
- Enrollment: 96 (Estimated)
- Study start: 2025-09-17 (Actual)
- Primary completion: 2028-12-31 (Estimated)
- Study completion: 2029-12-31 (Estimated)
- Allocation: Randomized
- InterventionModel: Parallel
- InterventionModelDescription: Parallell with cross-over option in non-surgical arm
- Masking: None
- PrimaryPurpose: Treatment
Brief Summary
A multicentre multinational RCT to investigate whether non-surgical treatment is non-inferior to surgical treatment for displaced extraarticular lateral clavicle fractures in adults.
Conditions
- Clavicle Fracture
Intervention / Treatment
- Procedure: Simple Sling and Physiotherapy
- Procedure: Surgical treatment
Primary Outcome Measures
-
Disabilites of the Arm, Shoulder and Hand (DASH)
(1 year)
A 30-item patient-reported outcome measure concerning shoulder, arm and hand function, with two additional 4-item modules concerning work and sports function. Min: 0 Max: 100. 0 representing no disability and 100 representing the most severe disability. A DASH score of 50 or more is often considered a cutoff for the presence of severe disability, while 20 or more suggests a medium level of disability.
Countries
Denmark, Finland, Norway, Sweden
Locations and Investigators
-
Odense University Hospital, Odense, Denmark (Not yet recruiting)
- Bjarke Viberg
-
Tampere University Hospital, Tampere, Finland (Not yet recruiting)
- Antti Launonen
-
Østfold Hospital Trust, Fredrikstad, Norway (Not yet recruiting)
- Frede Frihagen
-
Kalmar Regional Hospital, Kalmar, Sweden (Recruiting)
- Mats Ranbebo
-
Linköping University Hospital, Linköping, Sweden (Recruiting)
- Johan Scheer
-
Skane University Hospital, Malmo, Sweden (Recruiting)
- Jonas Nordin
-
Örebro University Hospital, Örebro, Sweden (Recruiting)
- Per Fischer
-
Danderyd Hospital, Stockholm, Sweden (Recruiting)
- Viktor Mili-Schmidt
-
Stockholm South Hospital, Stockholm, Sweden (Recruiting)
- Johanna Rundgren
-
Norrlands University Hospital, Umeå, Sweden (Recruiting)
- Jonas Sundkvist
-
Uppsala University Hopsital, Uppsala, Sweden (Recruiting)
- Pontus Christersson
Study Officials
- Olof Wolf, Associate Professor, MD (Principal Investigator) — Uppsala University Hospital and Uppsala University